Down-regulation of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor by HEXIM1 attenuates myocardial angiogenesis in hypoxic mice
- PMID: 25301555
- DOI: 10.1016/j.bbrc.2014.09.135
Down-regulation of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor by HEXIM1 attenuates myocardial angiogenesis in hypoxic mice
Abstract
Pulmonary hypertension (PH) sustains elevation of pulmonary vascular resistance and ultimately leads to right ventricular (RV) hypertrophy and failure and death. Recently, proangiogenic factors hypoxia-inducible factor-1 alpha (HIF-1α) and vascular endothelial growth factor (VEGF) have been known to promote left ventricular myocardial angiogenesis and lead to cardiac hypertrophy, and this would be involved in RV hypertrophy of PH patients. Previously, we revealed that overexpression of HEXIM1 prevents endothelin-1-induced cardiomyocyte hypertrophy and hypertrophic genes expression, and that cardiomyocyte-specific HEXIM1 transgenic mice ameliorates RV hypertrophy in hypoxia-induced PH model. Given these results, here we analyzed the effect of HEXIM1 on the expression of HIF-1α and VEGF and on myocardial angiogenesis of RV in PH. We revealed that overexpression of HEXIM1 prevented hypoxia-induced expression of HIF-1α protein and its target genes including VEGF in the cultured cardiac myocytes and fibroblasts, and that cardiomyocyte-specific HEXIM1 transgenic mice repressed RV myocardial angiogenesis in hypoxia-induced PH model. Thus, we conclude that HEXIM1 could prevent RV hypertrophy, at least in part, via suppression of myocardial angiogenesis through down-regulation of HIF-1α and VEGF in the myocardium under hypoxic condition.
Keywords: Angiogenesis; Cardiac hypertrophy; HEXIM1; HIF-1α; Pulmonary hypertension; VEGF.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart.J Biomed Sci. 2005;12(2):409-20. doi: 10.1007/s11373-005-3008-x. J Biomed Sci. 2005. PMID: 15942707
-
Cardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in mice.PLoS One. 2012;7(12):e52522. doi: 10.1371/journal.pone.0052522. Epub 2012 Dec 31. PLoS One. 2012. PMID: 23300697 Free PMC article.
-
HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland.Oncogene. 2010 Jun 24;29(25):3639-49. doi: 10.1038/onc.2010.110. Epub 2010 May 10. Oncogene. 2010. PMID: 20453883 Free PMC article.
-
Angiogenesis in gliomas: biology and molecular pathophysiology.Brain Pathol. 2005 Oct;15(4):297-310. doi: 10.1111/j.1750-3639.2005.tb00115.x. Brain Pathol. 2005. PMID: 16389942 Free PMC article. Review.
-
Harnessing the response to tissue hypoxia: HIF-1 alpha and therapeutic angiogenesis.Trends Cardiovasc Med. 2002 Nov;12(8):362-7. doi: 10.1016/s1050-1738(02)00186-x. Trends Cardiovasc Med. 2002. PMID: 12536123 Review.
Cited by
-
The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy.PLoS One. 2016 Jan 29;11(1):e0147597. doi: 10.1371/journal.pone.0147597. eCollection 2016. PLoS One. 2016. PMID: 26824665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials